(Credit- Frank Grillo Instagram)
Frank Grillo, the 60-year-old actor known for his roles in superhero films like Superman Peacemaker, recently opened up about how he gets in shape for the big screen. In a recent interview on the Men’s Health “Strong Talk” podcast, he candidly discussed his use of steroids, revealing that many actors use similar methods to prepare for roles.
Grillo spoke on his use of the steroid medication, and gave his view on its criticism. As a part of his Testosterone Replacement Therapy treatment, which helps improve symptoms of low testosterone, he took the medication, and it helped him deal with many age-related health issues.
Grillo shared that about six years ago, he found out his natural testosterone levels were low. To fix this, he started using testosterone replacement therapy. He says this treatment has helped him in many ways, like improving his sleep, speeding up his recovery after workouts, and making him feel happier in general. Grillo doesn't hide his use of steroids.
Also Read: Do This 1 Thing Before You Pop A Pill For Your Headache According To Pharmacist
He pushes back against people who call it “cheating,” arguing that as an actor, he isn’t competing in a sport like football or wrestling. Instead, he’s simply trying to look the part for a movie role and, in his words, is "not cheating at anything except aging." He also points out that when actors are hired for a superhero movie, there’s an expectation to look a certain way, and sometimes that means using medications like Anavar, a steroid that acts like testosterone.
Grillo claims that what he's doing is not uncommon in Hollywood. He believes that many other actors also use steroids to quickly achieve dramatic body transformations for their roles. He mentioned that drugs like Anavar and Deca, which is another type of steroid, are now often prescribed by doctors, which means their use can be monitored by a medical professional.
Grillo was very clear that incredibly muscular bodies aren't natural. He explains that it's just not realistic for someone to look one way for most of the year and then suddenly gain 35 pounds of muscle. He says that while many actors might not want to talk about it, everyone in the industry knows exactly what’s going on.
According to US National Cancer Institute, Oxandrolone is a man-made drug that's very similar to testosterone, a natural hormone in our bodies. It works by attaching to and activating certain receptors, which are like tiny switches in our cells. Because of this, oxandrolone is used for several reasons, including:
Testosterone replacement therapy: To help men who have low testosterone levels.
HIV-wasting syndrome: To help people with HIV who are losing a lot of weight and muscle.
Other conditions: To help the body hold onto more nitrogen (which is key for building muscle) and to increase lean muscle mass.
According to Hospital for Special Surgery (HSS), as men get older, it's common for them to experience a natural decline in both testosterone and muscle mass. While this is a normal part of aging, there are ways to fight back against it.
Testosterone is a crucial hormone for men. It helps build muscle by creating proteins, which in turn increases muscle strength. Starting around age 40, a man's testosterone levels gradually drop by about 1-2% each year. This decline can lead to symptoms like fatigue, hair loss, and depression, but many men don't realize what's causing these changes because testosterone levels aren't always checked during a routine doctor's visit.
Credit: Canva
Squirrels could be natural hosts of the mpox virus (MPXV) -- that causes monkeypox disease -- according to a recent study by German researchers.
The team from the Helmholtz Institute for One Health (HIOH) identified the fire-footed rope squirrel (Funisciurus pyrropus) as a likely natural reservoir of the MPXV.
The study published in the journal Nature revealed that sooty mangabeys – a primate found in West Africa -- can contract mpox by eating infected squirrels. The disease may present mild lesions, but it can also cause more severe skin lesions or even be fatal.
"Identifying the animal sources of the virus and the exposure routes that lead to inter-species transmission are key steps towards understanding spillover mechanisms and developing effective prevention measures to mitigate the risk of transmission to humans," said Livia V. Patrono, one of the senior authors at HIOH.
While squirrels have long been suspected as potential reservoirs for MPXV, their role was confirmed after an investigation of an mpox outbreak among wild sooty mangabeys (Cercocebus atys) in Côte d'Ivoire.
During the outbreak, reported in early 2023, nearly one-third of the primates showed clinical signs of disease, and four infants died.
The team conducted viral genome sequencing and found that the infected monkeys carried a virus that was nearly identical to an MPXV strain identified in a fire-footed rope squirrel found dead 12 weeks earlier nearby.
Further, the team analyzed fecal samples from the mangabeys. A sample collected eight weeks before the outbreak's onset contained DNA from both the virus and the rope squirrel. This provided strong evidence of interspecies transmission at that moment.
Sooty mangabeys have been previously observed catching and eating fire-footed rope squirrels, which provide a direct route for the transmission of viruses.
Although mpox is no longer a public health emergency, outbreaks of clade I and clade II strains of the mpox virus are continuing in many countries around the world, especially in Africa.
Last week, Madagascar announced the country's first death from mpox, a 3-year-old girl from the island nation’s eastern city of Toamasina.
The WHO has also confirmed that two cases of the recombinant strain – combining genomic elements of clades Ib and IIb of the monkeypox virus (MPXV) – have been identified to date: one in the United Kingdom and one in India.
Mpox is an infectious disease caused by the monkeypox virus (MPXV), part of the Orthopoxvirus genus, which also includes the virus that causes smallpox.
It spreads through close physical contact, including sexual contact, and in some cases through contaminated materials or respiratory droplets.
Symptoms typically include fever, swollen lymph nodes, rash, and/or lesions.
The global health body has also urged all countries to “remain alert to the possibility of MPXV genetic recombination.” It has also urged for continued epidemiological surveillance, sequencing, vaccination of at-risk groups, and infection prevention and control measures.
Credit: Canva
An international group of scientists has created an artificial intelligence tool that can estimate a woman’s likelihood of developing breast cancer within the next four years.
The AI tool, known as the BRAIx risk score, analyzes mammogram images to generate an individualized risk assessment and flag women who may face a higher chance of developing the disease.
It may not only show the current risk but also predict the future risk, enabling early detection and treatments for a better outcome.
According to the findings published in The Lancet Digital Health journal, nearly one in 10 women ranked in the top 2 percent of risk by the AI tool were diagnosed with breast cancer within four years. This was despite previously receiving a clear screening result.
“These risk scores enable future development of personalized screening pathways to transform population breast cancer screening and save lives,” said corresponding author Helen M. L. Frazer of the University of Melbourne.
Frazer noted that identifying women who appear cancer-free but carry very high risk -- comparable to those with inherited BRCA1 or BRCA2 mutations -- will unravel both hereditary and non-hereditary causes of breast cancer.
Breast cancer screening programs have significantly lowered mortality rates -- by roughly 40-50 percent among women aged 50 to 74. However, most screening systems still apply the same approach to all women, regardless of individual risk.
Traditional screening tools use genetics, breast density, and questionnaires to estimate breast cancer risk. On the other hand, new AI-based screening tools, such as BRAIx personalizes screening by gathering information already present in breast scan images to better identify who is at higher risk.
“Our results show that conventional mammographic density is a far weaker predictor of breast cancer risk than the BRAIx risk score, even for interval cancers,” the researchers said in the paper. Interval cancers are aggressive tumors diagnosed after a negative mammogram.
The BRAIx risk score was developed using mammograms from nearly 400,000 women. To prove its efficacy, the AI tool was tested on data from almost 96,000 women from Australia and then confirmed in an independent Swedish population of over 4,500 women.
The findings showed that:
The BRAIx risk score can:
Breast cancer continues to be the most common cancer among women worldwide.
A recent study published in The Lancet Oncology journal predicted that the number of new cases of the deadly disease will reach more than 3.5 million globally in 2050 -- rising by a third from 2.3 million in 2023.
Annual deaths from the disease will also rise by 44 percent -- from around 764,000 to 1.4 million.
However, not smoking, getting sufficient physical activity, lowering red meat consumption, and having a healthy weight can help prevent over a quarter of healthy years lost to illness and premature death from breast cancer.
Credit: Canva
People who survived a COVID-19 infection can be at significant risk for kidney disease, acute kidney injury, and chronic kidney disease. compared to individuals who were not infected, according to a study.
The study, published online in the journal Communications Medicine, revealed that COVID patients have
“While we’re in the post-pandemic era, this shows that COVID-19 history is an important variable when considering the long-term impact of the infection on kidney function and disease,” said first author Yue Zhang, who was at Pennsylvania State University, US, while conducting the study. Zhang is currently a postdoctoral scholar at Johns Hopkins Bloomberg School of Public Health.
For the study, data on over 3 million working-age adults in the United States were analyzed.
The team compared the effect of influenza, another common viral infection that affects kidney health, and people with a history of COVID infection on kidney infections.
Using a machine learning model, the individuals were followed between 180 and 540 days for the emergence of new acute or sudden kidney disease.
The results showed that:
The Penn State researchers explained that kidney cells express high levels of the primary protein receptors that SARS-CoV-2 uses to enter and infect cells. Kidney cells also produce specialized enzymes that help viruses enter cells.
According to Kidney Health Australia, an acute COVID infection can impact the kidneys with fevers and respiratory symptoms, and/or worsening blood sugar control.
The US National Institutes of Health stated that renal dysfunction is an increasing clinical indicator of COVID propagation.
Citing several studies, the NIH said that the most common clinical manifestation is proteinuria -- found in more than half of the COVID patients. In addition, hematuria, elevated blood urea nitrogen, and elevated serum creatinine are other common features in Covid survivors with poor kidney health.
Nasr Ghahramani, Professor of Medicine at Penn State College of Medicine, stressed the need for COVID survivors, especially those with diabetes and high blood pressure, to take "more frequent and more prolonged monitoring of their kidney function" to enable early detection and better outcomes.
© 2024 Bennett, Coleman & Company Limited